Works matching Cisplatin

Results: 5000
    1
    2
    3
    4
    5
    6

    Efficacy and Toxicity of Cisplatin and Capecitabine Combination in the First-Line Treatment of Patients with Advanced Gastric Cancer: A Multicenter Study by the Anatolian Society of Medical Oncology.

    Published in:
    UHOD: International Journal of Hematology & Oncology / Uluslararasi Hematoloji Onkoloji Dergisi, 2016, v. 26, n. 2, p. 96, doi. 10.4999/uhod.161429
    By:
    • CILTAS, Aydın;
    • BUYUKBERBER, Suleyman;
    • TOPCU, Turkan O.;
    • KUCUKONER, Mehmet;
    • UYETURK, Ummugul;
    • CIHAN, Sener;
    • SENDUR, Mehmet A.;
    • BUDAKOGLU, Burcin;
    • KEFELI, Umut;
    • YILDIZ, Ramazan;
    • GOKSEL, Gamze;
    • BERK, Veli;
    • BALAKAN, Ozan;
    • OKSUZOGLU, Berna;
    • UNCU, Dogan;
    • COSKUN, Ugur;
    • OZDEMIR, Feyyaz;
    • BENEKLI, Mustafa
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18

    Meta-analysis of three randomized trials of capecitabine plus cisplatin (XP) versus S-1 plus cisplatin (SP) as first-line treatment for advanced gastric cancer.

    Published in:
    International Journal of Clinical Oncology, 2023, v. 28, n. 11, p. 1501, doi. 10.1007/s10147-023-02402-1
    By:
    • Nishikawa, Kazuhiro;
    • Kawakami, Hisato;
    • Shimokawa, Toshio;
    • Fujitani, Kazumasa;
    • Tamura, Shigeyuki;
    • Endo, Shunji;
    • Kobayashi, Michiya;
    • Kawada, Junji;
    • Kurokawa, Yukinori;
    • Tsuburaya, Akira;
    • Yoshikawa, Takaki;
    • Sakamoto, Junichi;
    • Satoh, Taroh
    Publication type:
    Article
    19
    20
    21

    Comparative effectiveness of gemcitabine plus cisplatin versus methotrexate, vinblastine, doxorubicin, plus cisplatin as neoadjuvant therapy for muscle-invasive bladder cancer.

    Published in:
    Cancer (0008543X), 2015, v. 121, n. 15, p. 2586, doi. 10.1002/cncr.29387
    By:
    • Galsky, Matthew D.;
    • Pal, Sumanta K.;
    • Chowdhury, Simon;
    • Harshman, Lauren C.;
    • Crabb, Simon J.;
    • Wong, Yu‐Ning;
    • Yu, Evan Y.;
    • Powles, Thomas;
    • Moshier, Erin L.;
    • Ladoire, Sylvain;
    • Hussain, Syed A.;
    • Agarwal, Neeraj;
    • Vaishampayan, Ulka N.;
    • Recine, Federica;
    • Berthold, Dominik;
    • Necchi, Andrea;
    • Theodore, Christine;
    • Milowsky, Matthew I.;
    • Bellmunt, Joaquim;
    • Rosenberg, Jonathan E.
    Publication type:
    Article
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32

    Cisplatin and cisplatin analogues perfusion through isolated rat heart: the effects of acute application on oxidative stress biomarkers.

    Published in:
    Molecular & Cellular Biochemistry, 2018, v. 439, n. 1/2, p. 19, doi. 10.1007/s11010-017-3132-8
    By:
    • Stojic, Isidora M.;
    • Zivkovic, Vladimir I.;
    • Srejovic, Ivan M.;
    • Nikolic, Tamara R.;
    • Jeremic, Nevena S.;
    • Jeremic, Jovana N.;
    • Djuric, Dragan M.;
    • Jovicic, Nemanja;
    • Radonjic, Katarina G.;
    • Bugarcic, Zivadin D.;
    • Jakovljevic, Vladimir L. J.;
    • Novokmet, Slobodan S.
    Publication type:
    Article
    33
    34

    Phase II trial of induction irinotecan-cisplatin followed by concurrent irinotecan-cisplatin and radiotherapy for unresectable, locally advanced gastric and oesophageal-gastric junction adenocarcinoma.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 1, p. 75, doi. 10.1007/s00280-010-1285-1
    By:
    • Rivera, Fernando;
    • Galán, Maica;
    • Tabernero, Josep;
    • Cervantes, Andres;
    • Vega-Villegas, Mª;
    • Gallego, Javier;
    • Laquente, Berta;
    • Rodríguez, Edith;
    • Carrato, Alfredo;
    • Escudero, Pilar;
    • Massutí, Bartomeu;
    • Alonso-Orduña, Vicente;
    • Cardenal, Adelaida;
    • Sáenz, Alberto;
    • Giralt, Jordi;
    • Yuste, Ana;
    • Antón, Antonio;
    • Aranda, Enrique
    Publication type:
    Article
    35
    36
    37
    38

    Systemic and tumor disposition of platinum after administration of cisplatin or STEALTH liposomal-cisplatin formulations (SPI-077 and SPI-077 B103) in a preclinical tumor model of melanoma.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2004, v. 53, n. 4, p. 329, doi. 10.1007/s00280-003-0719-4
    By:
    • Zamboni, William C.;
    • Gervais, Anne C.;
    • Egorin, Merrill J.;
    • Schellens, Jan H. M.;
    • Zuhowski, Elleanor G.;
    • Pluim, Dick;
    • Joseph, Erin;
    • Hamburger, Deborah R.;
    • Working, Peter K.;
    • Colbern, Gail;
    • Tonda, Margaret E.;
    • Potter, Douglas M.;
    • Eiseman, Julie L.
    Publication type:
    Article
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49

    Efficacy and Safety of First-Line Necitumumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in East Asian Patients with Stage IV Squamous Non-small Cell Lung Cancer: A Subgroup Analysis of the Phase 3, Open-Label, Randomized SQUIRE Study

    Published in:
    Cancer Research & Treatment, 2017, v. 49, n. 4, p. 937, doi. 10.4143/crt.2016.423
    By:
    • Keunchil Park;
    • Eun Kyung Cho;
    • Maximino Bello;
    • Myung-Ju Ahn;
    • Thongprasert, Sumitra;
    • Eun-Kee Song;
    • Soldatenkova, Victoria;
    • Depenbrock, Henrik;
    • Puri, Tarun;
    • Orlando, Mauro
    Publication type:
    Article
    50